Dysregulated angiogenic factors, especially low “proangiogenic” PlGF and high “antiangiogenic” sFlt-1/PlGF ratio, predict several placental syndromes, including preeclampsia, FGR and other adverse outcomes [11–15]. The gene discussed is PGF; the disease is preeclampsia.